Page values for "Loratadine"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Loratadine |
| brand | String | Claritin, Alavert, Tavist ND |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:H1_receptor_antagonists|Histamine H1 receptor antagonist (second-generation)]] • [[:Category:Antihistamines|Antihistamine]] |
| mechanism | String | '"`UNIQ--vote-0000061E-QINU`"' Less reliably anticholinergic than first-generation H1s; minimal antiemetic effect. Desloratadine (Clarinex) is the active enantiomer-of-metabolite version marketed as a Rx alternative. |
| uses | String | '"`UNIQ--vote-0000061F-QINU`"', '"`UNIQ--vote-00000620-QINU`"' |
| starting_dose | String | 10 mg PO once daily |
| preparations | String | 10 mg tablets; 5 mg ODT and chewables; 1 mg/mL oral syrup; combo Claritin-D (with pseudoephedrine, behind-counter) |
| fda_max | String | 10 mg/d (adults) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 1-3 hours (slower onset than cetirizine; symptom relief somewhat less) |
| duration | String | 24 hours |
| halflife | String | ~8 hours (parent); ~28 hours (desloratadine, the active metabolite, marketed separately as Clarinex)'"`UNIQ--ref-00000621-QINU`"' |
| bioavailability | String | High (oral; food prolongs absorption modestly)'"`UNIQ--ref-00000622-QINU`"' |
| pregnancy | String | Generally considered safe; widely used. Loratadine and cetirizine are the most-recommended 2nd-gen H1s in pregnancy and lactation.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC in US |